Immunological adjuvant efficacy of glycyrrhetinic acid liposome against Newcastle disease vaccine
Keywords: GA; glycyrrhetinic acid; GAL; glycyrrhetinic acid liposome; ND; Newcastle disease; IgG; immunoglobulins G; IgM; immunoglobulins M; BL; blank liposome; VC; vaccine control; PHA; phytohemagglutinin; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium